Shengxiang Biotechnology: Plans to establish a joint venture to acquire 100% equity of Huasi Wuwei

The Beijing News Shell Finance reported that on March 15, Shengxiang Bio announced that the company plans to jointly invest with its affiliate, Hunan Jinfurong Shengxiang Bio Equity Investment Partnership (Limited Partnership), to establish Hunan Shengwei Huasi Biotechnology Co., Ltd. (referred to as “Shengwei Huasi”), and to use it as the investment entity for the subsequent acquisition of 100% equity of Huasi Microbial Technology (Shenzhen) Co., Ltd. (referred to as “Huasi Micro”). The company will contribute a total of 65.438 million yuan from its own funds. After the transaction is completed, Shengwei Huasi and Huasi Micro will be included in the company’s consolidated financial statements.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments